Randox Laboratories | Evidence Investigator
COVID-19 Testing Solutions
In response to the COVID-19 pandemic, Randox has developed a diverse range of testing solutions designed to meet the individual and unique demands of both clinical laboratories and Point-of-Care (POC) settings.
Utilising Randox Biochip Technology, the Evidence Investigator will detect SARS-CoV-2, the new strain of coronavirus in less than 5 hours. A Point-of-Care Testing (POCT) solution is also available. Click here to find out more.
Why choose the Evidence Investigator?
Extended Coronavirus Assay – Hi-Plex Molecular Assay for SARS-CoV-2 and 9 other viral targets
Suitable for use with the Evidence Investigator from Randox, the Extended Coronavirus Array comprises 6 strains of coronavirus including SARS-CoV-2. The wider panel delivers a more comprehensive respiratory screen allowing differentiation between COVID-19 and other respiratory viruses with similar symptoms, ultimately enabling better treatment decisions to be made.
Specifications | |
Cat. Code | EV4418 |
Sample Type | Nasopharyngeal Swab |
Sample Volume | 5ul of Nucleic acid required for PCR detection |
Viral Targets | SARS-CoV-2 (COVID-19) Sarbecovirus (SARS, SARS Like, SARS-CoV-2) Coronavirus 229E/NL6 Coronavirus OC43/HKUI MERS Coronavirus Adenovirus A/B/C/D/E Enterovirus A/B/C Influenza A Influenza B Rhinovirus A/B |
SARS-CoV-2 Array – Lo-Plex Molecular Assay for SARS-CoV-2 (COVID-19)
Suitable for use with the Evidence Investigator from Randox, the SARS-CoV-2 Array detects both SARS-CoV-2 and Sarbecovirus (confirmatory target), to report COVID-19 positive patient samples.
Specifications | |
Cat. Code | EV4432 |
Sample Type | Nasopharyngeal Swab |
Sample Volume | 5ul of Nucleic acid required for PCR detection |
Viral Targets | SARS-CoV-2 (COVID-19) |